Rigel Pharmaceuticals

Director, Forecasting

Rigel Pharmaceuticals$215K — $260K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree with 10+ years, or Master's/PhD in relevant field
  • Experience in pharma/biotech/health care industries
  • Deep understanding of life sciences commercial data with SP/SD data knowledge preferred
  • Proven forecasting experience in biotech/pharma markets
  • Strong project management and decision-making abilities

Responsibilities

  • Update forecasts with 5-year projections and quarterly estimates
  • Provide quarterly CMC updates
  • Collaborate with research on market updates regarding addressable populations
  • Align sales goals with the leadership team
  • Deliver quarterly board updates

Benefits

  • Participation in annual bonus and equity incentive programs
  • Comprehensive medical, dental, and vision coverage
  • Life and disability insurance included
  • Flexible spending accounts available
  • 401(k) plan options
  • Generous paid time off and company holidays
Full Job Description
POSITION SUMMARY:

The Director of Forecasting will support the Commercial team in making efforts to understand the current market trends and growth trajectories of licensed products. This position entails quarterly estimates, long term projections and supporting our CMC department on the supply chain.

Salary Range: $215,000 to $260,000

ESSENTIAL DUTIES AND RESPONSIBILITIES :
  • Forecast updates including 5-year projections and quarterly estimates across all marketed products
  • CMC updates quarterly
  • Partnering with research to include any relevant market updates on addressable populations/opportunity
  • Aligning with the leadership team on sales goals
  • Board updates quarterly

EDUCATION AND EXPERIENCE :
  • Bachelor's degree with 10+ years or Master's degree/PhD
  • Required: Experience within pharma/biotech/health care industries and/or related industries
  • Preferred; Possess deep understanding of life sciences commercial data, including SP/SD data,

SKILL REQUIREMENTS :
  • Experience with forecasting in biotech/pharma markets
  • Possess strong critical thinking, intellectual curiosity, problem solving and analytical skills.
  • Solid project management and decision-making skills
  • Excellent PowerPoint and excel skills
  • Solid organizational, project management skills and ability to manage multiple projects at a time.
  • Proven success in managing and partnering with peers, internal stakeholders and external vendors.

COMPENSATION AND BENEFITS:

The anticipated salary range for this position is Premium (SFBA/NY/Boston Area) $215,000 to $260,000. The actual salary offered will depend on several factors, including experience, qualifications, geographic location, internal equity, and business needs.

This position is eligible to participate in Rigel's annual bonus program and is eligible for equity incentive awards, subject to the terms of the applicable plans. This position is not commission-based.

Rigel offers eligible employees a comprehensive benefits package, including medical, dental, and vision coverage; life and disability insurance; flexible spending accounts; a 401(k) plan; paid time off; paid company holidays; and other benefits.

WORKING CONDITIONS:
  • PHYSICAL DEMANDS: While performing the duties of this job, the employee is required to stand, walk; sit; talk and hear. Specific vision abilities required by this job include close vision, distance vision, peripheral vision, depth perception and the ability to adjust focus.
  • WORK ENVIRONMENT: The noise level in the work environment is usually moderate. Some travel may be required.

About Rigel Pharmaceuticals

Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Rigel's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA approved product is TAVALISSE® (fostamatinib disodium hexahydrate) tablets, indicated for the treatment of thrombocytopenia in adult patients with chronic immune thrombocytopenia (ITP) who have had an insufficient response to a previous treatment. Rigel's current clinical programs include Phase 3 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy.
Learn more about Rigel Pharmaceuticals
Size
165 employees
Market Cap
$200.4 million
Industry
Net Income
-$29.7 million
Founded
1996
5 Year Trend
+48.9%
Revenue
$108.6 million
NASDAQ

Similar Jobs

More Jobs at Rigel Pharmaceuticals

More Pharmaceuticals & Biotech Jobs

Find similar Director, Forecasting jobs: